AstraZeneca PLC (FRA:ZEG)
134.65
+2.40 (1.81%)
At close: Aug 14, 2025, 10:00 PM CET
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
€510,187
Profits / Employee
€74,901
Market Cap
208.82B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 94,300 | 4,400 | 4.89% |
Dec 31, 2023 | 89,900 | 6,400 | 7.66% |
Dec 31, 2022 | 83,500 | 400 | 0.48% |
Dec 31, 2021 | 83,100 | 7,000 | 9.20% |
Dec 31, 2020 | 76,100 | 5,500 | 7.79% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
SAP SE | 109,121 |
Siemens Aktiengesellschaft | 327,000 |
Deutsche Telekom AG | 198,194 |
Allianz SE | 156,626 |
Siemens Energy AG | 98,000 |
Rheinmetall AG | 28,539 |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
Deutsche Bank Aktiengesellschaft | 89,753 |
AstraZeneca News
- 1 day ago - The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact - PRNewsWire
- 2 days ago - UK Government, Eli Lilly Partner To Target Obesity Health Gaps - Benzinga
- 3 days ago - AstraZeneca: Great Portfolio, But Not A Great Price - Seeking Alpha
- 5 days ago - Melrose boss soars to top of the Footsie pay league - This is Money
- 7 days ago - Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) and adults with generalized myasthenia gravis (gMG) - Benzinga
- 8 days ago - SOPHiA GENETICS reaffirms $72M–$76M 2025 revenue guidance as AstraZeneca deal drives BioPharma outlook - Seeking Alpha
- 9 days ago - EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data - Benzinga
- 9 days ago - SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes - PRNewsWire